The results showed inhibitory effects of miR-346 on HCC proliferation can be partially neutralized by the over-expression of SMYD3, which implied SMYD3 was an oncogene in HCC as a target of miR-346. This evidence concerns the gene SMYD3 and hepatocellular carcinoma.